1. Characterization of zolbetuximab in pancreatic cancer models
   Ӧzlem Türeci et al, 2019, OncoImmunology CrossRef
2. Diseases of the Pancreas Involving Channels/Transporters
   David C. Whitcomb, 2016, Ion Channels and Transporters of Epithelia in Health and Disease CrossRef
3. Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer
   Qian Xu et al, 2024, Frontiers in Oncology CrossRef
4. Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases
   Fangqian Du et al, 2024, Journal of Hepatocellular Carcinoma CrossRef
5. Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer
   Daisuke Kyuno, 2014, World Journal of Gastroenterology CrossRef
6. Claudin and pancreatic cancer
   Chen Wang et al, 2023, Frontiers in Oncology CrossRef
7. Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive Cancers
   Weixiang Zhong et al, 2022, Frontiers in Immunology CrossRef
8. Molecular Classification and Pathogenesis of Pancreatic Adenocarcinoma and Targeted Therapies: A Review
   Samantha M. Ruff et al, 2024, Frontiers in Bioscience-Landmark CrossRef
9. Claudins: from gatekeepers of epithelial integrity to potential targets in hepato-pancreato-biliary cancers
   Hyein Jeon et al, 2024, Frontiers in Oncology CrossRef